NOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment. Comment letters have been submitted for the following:
- December 31, 2019 – Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs CMS-5528-ANPRM
- January 25, 2019 – Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses, CMS-4180-P
- April 3, 2019 – Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees